Cytyc Eyes InDuct Expanded Coverage, Product Indications
This article was originally published in The Gray Sheet
Executive Summary
Empire BlueCross BlueShield's positive coverage policy for Cytyc's InDuct ductal lavage device has mitigated the firm's concern that reimbursement could be an obstacle to increased adoption of the breast cancer risk assessment tool
You may also be interested in...
Cytyc Prepares To Launch ThinPrep Imager; Women’s Health Recap For 2002
Cytyc's ThinPrep and TriPath's SurePath liquid-based cytology Pap tests could receive a boost in 2003 from a positive NICE technology assessment review
Cytyc Prepares To Launch ThinPrep Imager; Women’s Health Recap For 2002
Cytyc's ThinPrep and TriPath's SurePath liquid-based cytology Pap tests could receive a boost in 2003 from a positive NICE technology assessment review
Cytyc’s InDuct
CareFirst BlueCross BlueShield positive coverage decision for the ductal lavage procedure will provide reimbursement for 3.1 mil. members in Northern Virginia, Washington D.C., Maryland and Delaware. The decision follows Empire BlueCross BlueShield positive coverage policy and further mitigates the firm's concern that reimbursement could be an obstacle to increased adoption of the breast cancer risk assessment tool (1"The Gray Sheet" Jan. 28, 2002, p. 13)...